Skip to content

奥斯卡健康

US · OSCR #1512 按市值排名 上市于 2021
31.89 -1.58 -4.72%
实时 - 追踪5344个代码 - 心跳于14秒前 · 2026-10-16 20:01

✦ 量化股权信号 计算方式说明

减持
  • 最近一期(2026/Q3)披露持股的机构数量增加了4家。
  • 机构持股总比例下降了2.2个百分点。

机构持股

机构持股比例
73.63% -2.16pp
机构数量
471 +4
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Mutual Fund42.02%
VC/PE Fund11.82%
Hedge Fund11.57%
Individual/Insider3.85%
Private Company3.74%
Public Company2.63%
Government Pension Fund1.30%
Insurance Company0.30%
Family Office/Trust0.17%
Other22.61%

主要股东 截至 2026-09-18

Thrive Capital Management, LLC 10.66% · 32.86M 股
BlackRock 6.68% · 20.59M 股
T. Rowe Price Group, Inc. 5.28% · 16.29M 股
D. E. Shaw & Co., L.P. 4.10% · 12.64M 股
Vanguard Capital Management, LLC 3.95% · 12.19M 股
Vanguard Portfolio Management, LLC 3.58% · 11.03M 股
American Century Investment Management 2.94% · 9.06M 股
Jane Street Group, LLC 2.06% · 6.37M 股
Mark Bertolini 2.00% · 6.15M 股
Geode Capital Management, LLC 1.89% · 5.82M 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 18次买入 · 32次卖出

姓名职务持股比例
Thrive Capital Management, LLC -- 10.66%
Mark Bertolini Chief Executive Officer 2.00%
Mario Schlosser Co-Founder, CTO, President of Technology & Director 0.78%
Richard Blackley Chief Financial Officer 0.27%
Siddhartha Sankaran Director 0.26%
Jeffery Boyd Independent Chairperson 0.20%
Joshua Kushner Co-Founder & Vice Chairman 0.15%
Victoria Baltrus Chief Accounting Officer 0.07%
Vanessa Wittman Independent Director 0.03%
William Gassen Independent Director 0.02%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-17 Vanessa Wittman Independent Director Automatic Disposition -25,000 $32.24
2026-09-17 Thrive Capital Management, LLC -- Other Acquisition +6,343,617 --
2026-09-17 Thrive Capital Management, LLC -- Other Disposition -12,687,234 --
2026-09-17 Thrive Capital Management, LLC -- Other Disposition -6,343,617 --
2026-09-02 Janet Liang EVP & Principal Operating Officer Automatic Disposition -10,360 $31.45
2026-09-02 Mario Schlosser Co-Founder, CTO, President of Technology & Director Automatic Disposition -31,422 $31.45
2026-09-02 Richard Blackley Chief Financial Officer Automatic Disposition -28,869 $31.45
2026-09-02 Adam McAnaney -- Automatic Disposition -9,092 $31.45
2026-09-02 Victoria Baltrus Chief Accounting Officer Automatic Disposition -958 $31.45
2026-08-27 Mario Schlosser Co-Founder, CTO, President of Technology & Director Derivative Exercise and Sale -750,000 --
2026-08-27 Mario Schlosser Co-Founder, CTO, President of Technology & Director Intent to Sell (Form 144) -150,000 $30.79
2026-08-26 Mario Schlosser Co-Founder, CTO, President of Technology & Director Intent to Sell (Form 144) -600,000 $30.34
2026-08-19 Jeffery Boyd Independent Chairperson Intent to Sell (Form 144) -288,514 $33.15
2026-08-17 Richard Blackley Chief Financial Officer Open Market Disposition -18,750 $31.74
2026-08-12 Jeffery Boyd Independent Chairperson Intent to Sell (Form 144) -288,513 $30.11
2026-08-09 Jeffery Boyd Independent Chairperson Intent to Sell (Form 144) -134,370 $28.27
2026-08-09 Jeffery Boyd Independent Chairperson Intent to Sell (Form 144) -116,666 $28.13
2026-07-08 Siddhartha Sankaran Director Other Derivative Acquisition +858 --
2026-07-08 William Gassen Independent Director Other Derivative Acquisition +684 --
2026-07-08 David Plouffe Independent Director Other Derivative Acquisition +681 --

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:01:13 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

奥斯卡健康 讨论区 0 条评论

发表评论